Session » (0199–0209) Infection-related Rheumatic Disease Poster
- 10:30AM-12:30PM
-
Abstract Number: 0209
A Retrospective Safety Analysis based on Platelets in Arthrocentesis and Joint injections in Cancer Patients
- 10:30AM-12:30PM
-
Abstract Number: 0208
Current practices and challenges in tuberculosis screening and preventive treatment among patients with rheumatic diseases: A multiregional physician survey in China
- 10:30AM-12:30PM
-
Abstract Number: 0204
Immunogenicity and safety summary for the chikungunya virus-like particle vaccine development programme
- 10:30AM-12:30PM
-
Abstract Number: 0205
Implementation of the Varicella Zoster virus vaccine and its Real-World effectiveness
- 10:30AM-12:30PM
-
Abstract Number: 0199
Pain Phenotypes and Social Determinants of Health in Chronic Chikungunya Arthritis: A Cross-Sectional Study
- 10:30AM-12:30PM
-
Abstract Number: 0206
Prospective Controlled Study of Humoral Response to Recombinant Zoster Vaccine in Cyclophosphamide-Treated Autoimmune Rheumatic Disease Patients: No Additional Impairment Compared to Other Immunosuppressive Therapies
- 10:30AM-12:30PM
-
Abstract Number: 0201
Real-World study of immunogenicity and safety of the adjuvant recombinant vaccine against varicella zoster virus in patients with immune-mediated inflammatory diseases treated with Janus Kinase Inhibitors in comparison with healthy individuals
- 10:30AM-12:30PM
-
Abstract Number: 0203
Risk Factors for Cytomegalovirus Infection in Patients Receiving Prolonged High-Dose Corticosteroids for Rheumatic Diseases: A Retrospective Cohort Study
- 10:30AM-12:30PM
-
Abstract Number: 0202
Saudi Society for Rheumatology Consensus Recommendation on Vaccination Strategies in Adults Saudi with Autoimmune Rheumatic Disorders